Pfizer pledges not to pursue profits with products in 45 countries

25 May 2022
pfizer_black_new_large

US pharma giant Pfizer (NYSE: PFE) has launched an initiative that it calls ‘An Accord for a Healthier World’.

The company, which has seen its sales and profits spiral since the COVID-19 pandemic, aims to provide all of Pfizer’s patented, high-quality medicines and vaccines available in the USA or the European Union on a not-for-profit basis to 1.2 billion people in 45 lower-income countries.

"As we learned in the global COVID-19 vaccine roll-out, supply is only the first step to helping patients"With this initiative, Pfizer says that it wants to ‘greatly reduce the health inequities that exist between many lower-income countries and the rest of the world’.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Pharmaceutical